Abstract
Aims: In view of the main deficiency of biological valve prostheses – their frequent degeneration, we analysed the impact of a permanent post-operative antithrombotic therapy (PPATT) after the aortic valve replacement with biological prostheses (BAVP) on their degeneration rate among 142 patients who had been operated on with aortic valve replacement with biological prostheses (141 Carpentier-Edwards porcine prostheses and 1 allograft aortic valve) between July 1976 and December 1980 in our clinic.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
